Total Reports
41
FDA CVM filings
Horse /
FDA CVM · 2025 release 41 reports on file
Paso Fino - FDA Adverse Event Profile
Adverse-event records for Paso Fino (Horse) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Among horse breeds, Paso Fino is #286 by FDA report volume; 2.4% of its 41 reports (1) were death-coded.
- #286
- most-reported horse breed
- 2.4%
- death-coded report share
- 7
- Lethargy (see also Central nervous system depression in 'Neurological') - top reaction
- 16.4 yr
- average age at report
Read report counts next to breed popularity: a bigger number often just means more owners and more vet visits.
Deaths Reported
1
of 41 reports
Death Rate
2.4%
death-coded share
Avg Age at Report
16.4 yr
402.2 kg avg weight
Death-Coded Outcome Share
Paso Fino death-coded reports 2.4%
Cross-breed median
2.4% of 41 paso fino reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 402.2 kg (886.9 lbs)
Top Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 7
Injection site swelling 5
Overdose 5
Anorexia 4
Other abnormal test result NOS 4
Most Referenced Drugs
Pergolide Mesylate 9
Ivermectin(1.55%)/Praziquantel(7.75%) Paste 9
Ceftiofur Crystalline Free Acid 3
Omeprazole 3
Ceftiofur 2
Outcome Breakdown
Outcome Unknown
14 (43.8%)
Recovered/Normal
11 (34.4%)
Ongoing
6 (18.8%)
Died
1 (3.1%)
Gender Distribution
Male 27 (65.9%)
Female 14 (34.1%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2010 | 4 | |
| 2011 | 3 | |
| 2012 | 5 | |
| 2013 | 3 | |
| 2014 | 2 | |
| 2015 | 2 | |
| 2016 | 8 | |
| 2017 | 3 | |
| 2018 | 3 | |
| 2019 | 2 | |
| 2020 | 1 | |
| 2021 | 1 | |
| 2022 | 2 | |
| 2023 | 1 | |
| 2025 | 1 | |
Paso Fino Pet Health Insights
Paso Fino accounts for 41 FDA adverse event reports, ranking #286 by volume among horse breeds, with 1 reports (2.4%) coded as a death outcome. Mean age at report: 16.4 years, average weight 402.2 kg (886.9 lbs).
Top reported signs: Lethargy (see also Central nervous system depression in 'Neurological') (7), Injection site swelling (5), Overdose (5). Most-referenced drug: Pergolide Mesylate (9 reports), followed by Ivermectin(1.55%)/Praziquantel(7.75%) Paste (9) and Ceftiofur Crystalline Free Acid (3).
Outcome coding on 32 status-recorded reports is dominated by Outcome Unknown (43.8%). Annual submissions ranged 2,010-2,025 across 15 years on file.
Horse Breeds With a Similar Report Volume
Frequently Asked Questions
How many FDA adverse event reports involve Paso Fino? ▼
There are 41 adverse event reports involving Paso Fino in the FDA database, with 1 reports involving death (2.4% death rate). Paso Fino ranks #286 by report volume.
What are the most common adverse reactions reported for Paso Fino? ▼
The most commonly reported adverse reactions for Paso Fino are Lethargy (see also Central nervous system depression in 'Neurological') (7 reports), Injection site swelling (5 reports), Overdose (5 reports), Anorexia (4 reports), Other abnormal test result NOS (4 reports).
What drugs are most frequently associated with Paso Fino adverse events? ▼
The drugs most frequently referenced in Paso Fino adverse event reports are Pergolide Mesylate (9 reports), Ivermectin(1.55%)/Praziquantel(7.75%) Paste (9 reports), Ceftiofur Crystalline Free Acid (3 reports), Omeprazole (3 reports), Ceftiofur (2 reports).
What is the average age of Paso Fino in adverse event reports? ▼
The average age of Paso Fino at the time of adverse event reports is 16.4 years, with an average weight of 402.2 kg (886.9 lbs).
Does a high number of adverse event reports mean Paso Fino is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Paso Fino safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.